Class information for:
Level 1: LERCANIDIPINE//LERCANIDIPINE HYDROCHLORIDE//CAS 132866 11 6

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
29297 189 31.9 66%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
8 4 CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL 1276458
11 3       ATRIAL FIBRILLATION//CARDIAC & CARDIOVASCULAR SYSTEM//CATHETER ABLATION 130936
822 2             CALCIUM ANTAGONISTS//CALCIUM CHANNEL BLOCKERS//NIFEDIPINE 11902
29297 1                   LERCANIDIPINE//LERCANIDIPINE HYDROCHLORIDE//CAS 132866 11 6 189

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 LERCANIDIPINE authKW 9336847 47% 66% 88
2 LERCANIDIPINE HYDROCHLORIDE authKW 934752 5% 64% 9
3 CAS 132866 11 6 authKW 323126 1% 100% 2
4 REC 15 2375 PHARMACOLOGY authKW 323126 1% 100% 2
5 1 2 NAPHTHAQUINONE 4 SULPHONIC ACID SODIUM SALT NQS authKW 161563 1% 100% 1
6 AMINOMETHYLTHIAZOLES authKW 161563 1% 100% 1
7 ANTIHYPERTENSIVE FIXED COMBINATION authKW 161563 1% 100% 1
8 ARTERIL HYPERTENSION authKW 161563 1% 100% 1
9 AZOCARAMINE G authKW 161563 1% 100% 1
10 BIOLOGICAL SAMPLES SPIKED authKW 161563 1% 100% 1

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Pharmacology & Pharmacy 798 39% 0% 73
2 Peripheral Vascular Diseases 484 15% 0% 29
3 Cardiac & Cardiovascular System 216 14% 0% 27
4 Medicine, Research & Experimental 111 10% 0% 19
5 Chemistry, Analytical 88 11% 0% 20
6 Medicine, General & Internal 49 9% 0% 17
7 Urology & Nephrology 46 5% 0% 10
8 Biochemical Research Methods 41 6% 0% 11
9 Toxicology 34 5% 0% 9
10 Chemistry, Medicinal 19 4% 0% 7

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CATEDRA RIESGO CARDIOVASCSERV NEFROL 161563 1% 100% 1
2 COMPLESSO SOCIO SANIT I 161563 1% 100% 1
3 FORMAULAT DEV PHARMACOKINET 161563 1% 100% 1
4 MED INTERNA AMBROSIONI 161563 1% 100% 1
5 MED SCI AFFAIRS AUSTRALIA NEW ZEALAND 161563 1% 100% 1
6 REHABIL CAMPOLI TELESE 161563 1% 100% 1
7 SECT HUMAN ANANT 161563 1% 100% 1
8 SS REYES MADRID 161563 1% 100% 1
9 IL DRUG DISCOVERY NEW CHEM ENTITIES DEV 161561 1% 50% 2
10 BIOEQUIVALENCE PHARMACEUT STUDIES 80781 1% 50% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CARDIOVASCULAR THERAPY AND PREVENTION 7795 3% 1% 6
2 RUSSIAN JOURNAL OF CARDIOLOGY 3094 2% 1% 3
3 CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL 2724 5% 0% 9
4 BLOOD PRESSURE 2660 2% 0% 4
5 KARDIOLOGIYA 2465 5% 0% 10
6 DRUGS 2326 5% 0% 9
7 CURRENT MEDICAL RESEARCH AND OPINION 2313 4% 0% 8
8 CLINICAL THERAPEUTICS 1590 4% 0% 7
9 CARDIOVASCULAR DRUG REVIEWS 1535 1% 0% 2
10 CLINICAL DRUG INVESTIGATION 1178 2% 0% 4

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 LERCANIDIPINE 9336847 47% 66% 88 Search LERCANIDIPINE Search LERCANIDIPINE
2 LERCANIDIPINE HYDROCHLORIDE 934752 5% 64% 9 Search LERCANIDIPINE+HYDROCHLORIDE Search LERCANIDIPINE+HYDROCHLORIDE
3 CAS 132866 11 6 323126 1% 100% 2 Search CAS+132866+11+6 Search CAS+132866+11+6
4 REC 15 2375 PHARMACOLOGY 323126 1% 100% 2 Search REC+15+2375+PHARMACOLOGY Search REC+15+2375+PHARMACOLOGY
5 1 2 NAPHTHAQUINONE 4 SULPHONIC ACID SODIUM SALT NQS 161563 1% 100% 1 Search 1+2+NAPHTHAQUINONE+4+SULPHONIC+ACID+SODIUM+SALT+NQS Search 1+2+NAPHTHAQUINONE+4+SULPHONIC+ACID+SODIUM+SALT+NQS
6 AMINOMETHYLTHIAZOLES 161563 1% 100% 1 Search AMINOMETHYLTHIAZOLES Search AMINOMETHYLTHIAZOLES
7 ANTIHYPERTENSIVE FIXED COMBINATION 161563 1% 100% 1 Search ANTIHYPERTENSIVE+FIXED+COMBINATION Search ANTIHYPERTENSIVE+FIXED+COMBINATION
8 ARTERIL HYPERTENSION 161563 1% 100% 1 Search ARTERIL+HYPERTENSION Search ARTERIL+HYPERTENSION
9 AZOCARAMINE G 161563 1% 100% 1 Search AZOCARAMINE+G Search AZOCARAMINE+G
10 BIOLOGICAL SAMPLES SPIKED 161563 1% 100% 1 Search BIOLOGICAL+SAMPLES+SPIKED Search BIOLOGICAL+SAMPLES+SPIKED

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 BORGHI, C , (2009) LERCANIDIPINE IN ARTERIAL HYPERTENSION.CARDIOVASCULAR THERAPY AND PREVENTION. VOL. 8. ISSUE 7. P. 121-129 27 68% 0
2 FOMIN, VV , SVISTUNOV, AA , (2012) LERKANIDIPINE: EVOLUTION OF DIHYDROPYRIDINE CALCIUM ANTAGONISTS CONTINUES.KARDIOLOGIYA. VOL. 52. ISSUE 11. P. 75-79 19 76% 0
3 MINUSHKINA, LO , IOSAVA, IK , (2012) LERCANIDIPINE IN THE TREATMENT OF ARTERIAL HYPERTENSION.KARDIOLOGIYA. VOL. 52. ISSUE 12. P. 70-74 16 84% 0
4 BARRIOS, V , ESCOBAR, C , DE LA FIGUERA, M , LLISTERRI, JL , HONORATO, J , SEGURA, J , CALDERON, A , (2008) TOLERABILITY OF HIGH DOSES OF LERCANIDIPINE VERSUS HIGH DOSES OF OTHER DIHYDROPYRIDINES IN DAILY CLINICAL PRACTICE: THE TOLERANCE STUDY.CARDIOVASCULAR THERAPEUTICS. VOL. 26. ISSUE 1. P. 2 -9 17 85% 6
5 SASTRY, TM , RAMAKRISHNA, K , (2014) DETERMINATION OF LERCANIDIPINE HYDROCHLORIDE, AN ANTIHYPERTENSIVE AGENT VIA COORDINATION COMPLEXATION USING COBALT THIOCYANATE.JOURNAL OF THE INDIAN CHEMICAL SOCIETY. VOL. 91. ISSUE 3. P. 381 -386 12 100% 0
6 BURNIER, M , PRUIJM, M , WUERZNER, G , (2009) TREATMENT OF ESSENTIAL HYPERTENSION WITH CALCIUM CHANNEL BLOCKERS: WHAT IS THE PLACE OF LERCANIDIPINE?.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 5. ISSUE 8. P. 981-987 18 69% 11
7 BARRIOS, V , ESCOBAR, C , DE LA FIGUERA, M , LLISTERRI, JL , HONORATO, J , SEGURA, J , CALDERON, A , (2010) TOLERABILITY OF HIGH DOSES OF LERCANIDIPINE VERSUS HIGH DOSES OF OTHER DIHYDROPYRIDINES IN DAILY CLINICAL PRACTICE: THE TOLERANCE STUDY.CARDIOVASCULAR THERAPY AND PREVENTION. VOL. 9. ISSUE 8. P. 38-45 15 83% 0
8 POGOSOVA, GV , AUSHEVA, AK , KARPOVA, AV , SALBIEVA, AO , (2014) THIRD GENERATION CALCIUM ANTAGONIST LERCANIDIPINE: THE EVIDENCE BASE FOR CLINICAL DECISION.KARDIOLOGIYA. VOL. 54. ISSUE 2. P. 43 -46 14 74% 0
9 BANG, LM , CHAPMAN, TM , GOA, KL , (2003) LERCANIDIPINE - A REVIEW OF ITS EFFICACY IN THE MANAGEMENT OF HYPERTENSION.DRUGS. VOL. 63. ISSUE 22. P. 2449-2472 23 55% 48
10 BURNIER, M , PRUIJM, M , WUERZNER, G , (2010) TREATMENT OF ESSENTIAL HYPERTENSION WITH CALCIUM CHANNEL BLOCKERS: WHAT IS THE PLACE OF LERCANIDIPINE.RUSSIAN JOURNAL OF CARDIOLOGY. VOL. . ISSUE 2. P. 97-103 17 65% 0

Classes with closest relation at Level 1


Rank Class id link
1 10759 LACIDIPINE//MEBUDIPINE//NIFEDIPINE
2 61 HYPERTENSION//ISOLATED SYSTOLIC HYPERTENSION//BLOOD PRESSURE CONTROL
3 21385 AMLODIPINE//NIFEDIPINE GITS//MODERN APPROACH TO THE TREATMENT OF HYPERTENSION MATH TRIAL
4 21976 CILNIDIPINE//BENIDIPINE//AZELNIDIPINE
5 21605 POSTINFARCTION ARRHYTHMIAS//SPRINT STUDY GRP//CALCIUM CHANNEL BLOCKERS
6 3257 ISRADIPINE//FELODIPINE//JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
7 7760 HYDROCHLOROTHIAZIDE//AMLODIPINE BESYLATE//LOSARTAN POTASSIUM
8 12596 DESIALYLATED LOW DENSITY LIPOPROTEINS//CALCIUM ANTAGONISTS//INTRACELLULAR CHOLESTEROL ACCUMULATION
9 4584 PROTEINURIA//ANGIOTENSIN RECEPTOR BLOCKER//DUAL BLOCKADE
10 35331 ATTITUDES AND MANAGEMENT//CLINICAL TEST DATA//DISTILLATION ANALYSIS

Go to start page